Azenta, Inc. (NASDAQ:AZTA) Shares Acquired by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP lifted its position in Azenta, Inc. (NASDAQ:AZTA - Free Report) by 31.2% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 2,231,792 shares of the company's stock after acquiring an additional 530,408 shares during the period. Dimensional Fund Advisors LP owned 4.01% of Azenta worth $145,382,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in AZTA. Headlands Technologies LLC purchased a new position in Azenta during the third quarter valued at $33,000. Principal Securities Inc. bought a new position in Azenta during the 4th quarter valued at approximately $36,000. Northwest Financial Advisors purchased a new position in Azenta during the fourth quarter valued at $46,000. Neo Ivy Capital Management bought a new stake in Azenta in the third quarter worth $73,000. Finally, Covestor Ltd grew its stake in shares of Azenta by 17.5% in the third quarter. Covestor Ltd now owns 1,714 shares of the company's stock worth $86,000 after acquiring an additional 255 shares during the last quarter. Hedge funds and other institutional investors own 99.08% of the company's stock.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the stock. Needham & Company LLC decreased their price objective on shares of Azenta from $75.00 to $69.00 and set a "buy" rating for the company in a report on Thursday, May 9th. B. Riley raised their price target on Azenta from $61.00 to $79.00 and gave the stock a "buy" rating in a research note on Thursday, February 1st. Jefferies Financial Group started coverage on Azenta in a research report on Thursday, April 4th. They set a "hold" rating and a $64.00 price objective for the company. Evercore ISI lowered their target price on Azenta from $64.00 to $60.00 and set an "in-line" rating on the stock in a report on Thursday, April 4th. Finally, Stephens restated an "equal weight" rating and set a $70.00 price target on shares of Azenta in a research note on Thursday, February 8th. Four research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, Azenta has an average rating of "Hold" and an average price target of $68.40.

Azenta Price Performance

Shares of NASDAQ:AZTA traded down $0.47 during midday trading on Friday, hitting $50.87. The company had a trading volume of 388,789 shares, compared to its average volume of 504,360. Azenta, Inc. has a 12-month low of $40.41 and a 12-month high of $69.16. The company has a fifty day moving average of $55.67 and a two-hundred day moving average of $59.43. The company has a market cap of $2.74 billion, a price-to-earnings ratio of -18.77 and a beta of 1.51.

Azenta (NASDAQ:AZTA - Get Free Report) last released its quarterly earnings results on Wednesday, May 8th. The company reported $0.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.02 by $0.03. Azenta had a positive return on equity of 0.81% and a negative net margin of 23.12%. The business had revenue of $159.13 million during the quarter, compared to analyst estimates of $159.89 million. During the same quarter in the previous year, the company posted ($0.06) earnings per share. Azenta's revenue for the quarter was up 7.2% on a year-over-year basis. Research analysts expect that Azenta, Inc. will post 0.29 earnings per share for the current fiscal year.

About Azenta

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.